Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2372
Full metadata record
DC FieldValueLanguage
dc.contributor.authorY. Sun, Y. Sun-
dc.contributor.authorX. Chen, X. Chen-
dc.date.accessioned2022-08-09T15:44:30Z-
dc.date.available2022-08-09T15:44:30Z-
dc.date.issued2020-12-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2372-
dc.description.abstractLevonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: A meta­analysis of 19 randomized controlled trials Y. Sun1 , X. Chen1 , X. Yuan1 , L. Xu1 , Y.C. Jin1 , T.H. Ji1 , X.L. Wang1 , H.H. Dai1,∗ , W.J. Cheng1,∗ 1Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029 (P.R. China) Summary Background: The aim of this meta­analysis was to compare levonorgestrel intrauterine system (LNG­IUS) with oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection. Materials and Methods: Computerized literature search was performed in PubMed and several Chinese databases to screen for relevant trials. Quality assessment and meta­analysis were performed for the included trials. Results: A total of 19 randomized controlled trials were identified. Meta­analysis indicated that the LNG­IUS group was associated with lower recurrence rate of endometrial polyps than the oral progestin group (p < 0.0001), while there was no significant difference in the incidence of abnormal uterine bleeding between groups (p > 0.05). In terms of adverse effects related to progestin, the LNG­IUS group had significantly fewer adverse effects than the oral progestin group (p < 0.0001). Additionally, the LNG­IUS group had thinner endometrium and higher hemoglobin levels than the oral progestin group (p < 0.00001). Conclusion: The LNG­IUS was more effective and safer in preventing the recurrence of endometrial polyps after hysteroscopic resection than oral progestin. Key words: Endometrial polyps; Levonorgestrel intrauterine system; LNG­IUS; Oral progestin; Meta­analysisen_US
dc.subjectEndometrial polypsen_US
dc.subjectLevonorgestrel intrauterine systemen_US
dc.subjectLNG­IUSen_US
dc.subjectOral progestinen_US
dc.subjectMeta­analysisen_US
dc.titleLevonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: A meta­analysis of 19 randomized controlled trialsen_US
dc.typeArticleen_US
Appears in Collections:2. Clinical and Experimental Obstetrics & Gynecology

Files in This Item:
File Description SizeFormat 
0390-6663-47-6-821.pdf1.08 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.